Trifecta Capital Advisors’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-35
Closed -$5.57K 456
2023
Q3
$5.57K Hold
35
﹤0.01% 236
2023
Q2
$4.95K Hold
35
﹤0.01% 227
2023
Q1
$5.89K Hold
35
﹤0.01% 222
2022
Q4
$5.93K Buy
+35
New +$6.35K ﹤0.01% 211

Other funds holding RGEN

Trifecta Capital Advisors's RGEN Position: Q4 2023 in Review

Trifecta Capital Advisors sold out of Repligen (RGEN) in Q4 2023, closing a stake of 35 shares — an estimated $5.57K sold.

Trifecta Capital Advisors first reported a position in RGEN in Q4 2022 and held it in 4 quarters. The position peaked at $5.93K in Q4 2022. 466 funds tracked by Wall St. Rank hold RGEN as of Q4 2023.

  • Trifecta Capital Advisors reported no remaining Repligen position as of Q4 2023 after selling out during the quarter.
  • Trifecta Capital Advisors sold 35 Repligen shares in Q4 2023, an estimated $5.57K.
  • Trifecta Capital Advisors first reported a position in Repligen in Q4 2022 and held it in 4 quarters.
  • Trifecta Capital Advisors's Repligen position peaked at $5.93K in Q4 2022.
  • 466 funds tracked by Wall St. Rank held Repligen as of Q4 2023.

Based on Trifecta Capital Advisors's 13F filing for Q4 2023, filed 25 Jan 2024.